Carcinologic Speech Severity Index

University Hospital, Toulouse124 enrolled

Overview

The hypothesis of the present study is that an automatic assessment technic can measure the impact of the speech disorders on the communication abilities giving a severity index of speech in patients treated for head and neck and particularly for oral and pharyngeal cancer.

Study Type

INTERVENTIONAL

Allocation

Purpose

PREVENTION

Masking

NONE

Enrollment

124

Conditions

Head and Neck Cancer

Interventions

automatic speech processing toolPROCEDURE

Eligibility

Sex: ALLMin age: 18 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * Oral and Pharyngeal cancer T2 to T4 for having a wide dynamic of deficit * Treatment by surgery and/or radiotherapy and/or chemotherapy * Delay after the end of the treatment of minimum 6 months. Exclusion Criteria: * Patients with a previous speech disorders (ie stuttering… ) * Patients not able to perform the whole task

Outcomes

Primary Outcomes

carcinologic speech severity index

The main objective is to demonstrate that the carcinologic speech severity index (C2SI), obtained by an automatic speech processing tool, produces equivalent or superior outcomes than a score of speech intelligibility obtained by human listeners, in terms of quality of life foreseeing the speech handicap, after the treatment of oral and/or pharyngeal cancer.

Time frame: day 0

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.